Hypoglycemia in the newborn and infant
DD De Leon, P Thornton, CA Stanley… - Sperling pediatric …, 2021 - Elsevier
A newborn or infant with hypoglycemia presents an urgent diagnostic and therapeutic
challenge. The clinical features must be rapidly assessed and a plan of action developed …
challenge. The clinical features must be rapidly assessed and a plan of action developed …
Population pharmacokinetics of exendin‐(9‐39) and clinical dose selection in patients with congenital hyperinsulinism
Aims Congenital hyperinsulinism (HI) is the most common cause of persistent
hypoglycaemia in infants and children. Exendin‐(9‐39), an inverse glucagon‐like peptide 1 …
hypoglycaemia in infants and children. Exendin‐(9‐39), an inverse glucagon‐like peptide 1 …
Congenital hyperinsulinism and Poland syndrome in association with 10p13–14 duplication
D Giri, P Patil, R Hart, M Didi… - … & Metabolism Case …, 2017 - edm.bioscientifica.com
Poland syndrome (PS) is a rare congenital condition, affecting 1 in 30 000 live births
worldwide, characterised by a unilateral absence of the sternal head of the pectoralis major …
worldwide, characterised by a unilateral absence of the sternal head of the pectoralis major …
The diagnosis and management of congenital and adult-onset hyperinsulinism (nesidioblastosis)–literature review
AM Kowalewski, Ł Szylberg, A Kasperska… - Polish Journal of …, 2017 - termedia.pl
Congenital and adult-onset hyperinsulinism (CHI) must be taken under consideration in the
differential diagnosis of hypoglycaemia symptoms with endogenous hyperinsulinism …
differential diagnosis of hypoglycaemia symptoms with endogenous hyperinsulinism …
Case report: a difficult-to-diagnose case of hyperinsulinemic hypoglycemia surgically treated after developing acute pancreatitis
C Inoue, K Nishihama, A Hayasaki, Y Okano… - Frontiers in …, 2021 - frontiersin.org
The patient is a 28-year-old Japanese man diagnosed with severe congenital
hyperinsulinemic-hypoglycemia six months after birth. Clinical records revealed no imaging …
hyperinsulinemic-hypoglycemia six months after birth. Clinical records revealed no imaging …
Analysis of miRNA and mRNA expression in the dysregulation of insulin secretion in MIN6 cells exposed to microcystin-leucine-arginine
Y Chen, Y Zhou, X Wei, Y Yang, X Li, Y Xu, C Liu… - Toxicon, 2021 - Elsevier
Abstract Microcystin-leucine-arginine (MC-LR), produced by freshwater cyanobacteria, is a
potential pancreatic β-cell toxin. In this study, the function of the mouse pancreatic β-cell line …
potential pancreatic β-cell toxin. In this study, the function of the mouse pancreatic β-cell line …
[PDF][PDF] Hyperinsulinaemic hypoglycaemia: a new presentation of 16p11. 2 deletion syndrome
E Kostopoulou, A Dastamani, S Caiulo… - Clinical …, 2019 - drive.google.com
16p11. 2 microdeletion syndrome is a recognisable chromosomal anomaly caused by
microdeletions in the 16p11. 2 locus. It is characterized by developmental delay intellectual …
microdeletions in the 16p11. 2 locus. It is characterized by developmental delay intellectual …
An uncommon cause of recurrent presyncope, dizziness, and tachycardia: a case report of diffuse, adult-onset nesidioblastosis/non-insulinoma pancreatogenous …
MP Dieterle, A Husari, SN Prozmann, H Wiethoff… - Biomedicines, 2023 - mdpi.com
Neurovegetative and autonomic symptoms are common presentations of various diseases,
ranging from psychosomatic to severe organic disorders. A 23-year-old man presented with …
ranging from psychosomatic to severe organic disorders. A 23-year-old man presented with …
Demographics, in-hospital analysis, and prevalence of 33 rare diseases with effective treatment in Shanghai
X Cai, GZ Genchev, P He, H Lu, G Yu - Orphanet Journal of Rare …, 2021 - Springer
Background Rare diseases are ailments which impose a heavy burden on individual
patients and global society as a whole. The rare disease management landscape is not a …
patients and global society as a whole. The rare disease management landscape is not a …
Asymptomatic congenital hyperinsulinism due to a glucokinase‐activating mutation, treated as adrenal insufficiency for twelve years
K Morishita, C Kyo, T Yonemoto… - Case Reports in …, 2017 - Wiley Online Library
Congenital hyperinsulinism (CHI) caused by a glucokinase‐(GCK‐) activating mutation
shows autosomal dominant inheritance, and its severity ranges from mild to severe. A 43 …
shows autosomal dominant inheritance, and its severity ranges from mild to severe. A 43 …